SYRESpyre Therapeutics, Inc.Mar 7, 2019Q4 2018
Read transcript →Spyre Therapeutics, Inc. (SYRE) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$88.00
-4.32%
Mkt Cap $7.90B
SYRESpyre Therapeutics, Inc.Mar 7, 2019SYRESpyre Therapeutics, Inc.Mar 23, 2017Q4 2016
Read transcript →